glycerol and everolimus

glycerol has been researched along with everolimus in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Banuelos, CA; Caley, DP; Imamura, Y; Kato, M; Leung, JK; Mawji, NR; Sadar, MD; Wang, J	1

Other Studies

1 other study(ies) available for glycerol and everolimus

Article	Year
Cotargeting Androgen Receptor Splice Variants and mTOR Signaling Pathway for the Treatment of Castration-Resistant Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 2016, 06-01, Volume: 22, Issue:11 Topics: Alternative Splicing; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Benzhydryl Compounds; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Everolimus; Gene Expression Regulation, Neoplastic; Glycerol; Imidazoles; Male; Mice, Inbred NOD; Mice, SCID; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Protein Isoforms; Quinolines; Receptors, Androgen; Signal Transduction; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays	2016

Article

Year

Cotargeting Androgen Receptor Splice Variants and mTOR Signaling Pathway for the Treatment of Castration-Resistant Prostate Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2016, 06-01, Volume: 22, Issue:11

Topics: Alternative Splicing; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Benzhydryl Compounds; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Everolimus; Gene Expression Regulation, Neoplastic; Glycerol; Imidazoles; Male; Mice, Inbred NOD; Mice, SCID; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Protein Isoforms; Quinolines; Receptors, Androgen; Signal Transduction; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays

2016